MedTrace Logo

Asian Myeloproliferative Neoplasm (MPN) Registry

NCT05882773 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-05-31

No results posted yet for this study

Summary

This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.

Conditions

  • Myeloproliferative Neoplasm
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Post-polycythemia Vera Myelofibrosis
  • Post-essential Thrombocythemia Myelofibrosis
  • Primary Myelofibrosis
  • Primary Myelofibrosis, Prefibrotic Stage
  • Primary Myelofibrosis, Fibrotic Stage

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Harinder Gill, MD · The University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2026-05-31
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882773 on ClinicalTrials.gov